Our most recent study with GnRH-(1–5) has determined that its effects are dependent on increased matrix metallopeptidase-9 (MMP-9) enzymatic activity in two different endometrial cancer cell models, the Ishikawa and ECC-1 cell lines (57). The gene discussed is MMP9; the disease is endometrial cancer.